TABLE 1. Human Exposure Concentrations and (No) Effect Concentrations for Inhibition of VGCCs of Endosulfan, Cypermethrin and Chlorpyrifos (in μM) with the Estimated Margin of Exposurea.
| Insecticide | Human occupational exposure | (No) effect concentrations for VGCC inhibition | Margin of exposureb | |||
|---|---|---|---|---|---|---|
| Concentration | Estimated from | IC50 | IC20 | NOEC | ||
| α-cypermethrin | 0.0010–0.0037 | Internal daily dose from urinary metabolitec | 0.239 | 0.03 | 0.01 | 2.7–9.7 |
| Chlorpyrifos | 0.0071–0.1520 | Absorbed daily dose from urinary metabolited | 0.899 | 0.08 | 0.01 | 0.07–1.4 |
| Endosulfan | 1.3371 | Blood serume | 0.25 | 0.12 | 0.01 | 0.007 |
aRisk estimates presented here did not take into account possible detoxification or bioactivation pathways that may influence the risk assessment.
bMargin of exposure: NOEC/exposure concentration; NOEC, no-observed-effect concentration.
cSingleton et al., 2014.
dPhung et al., 2012.
eDalvie et al., 2009.